We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2003;290(24):3167. doi:10.1001/jama.290.24.3167.
Text Size: A A A
Published online


Two new imaging strategies—whole-body magnetic resonance imaging (MRI) and whole-body dual-modality positron emission tomography and computed tomography (PET/CT)—offer the possibility of whole-body coverage for tumor staging in a single diagnostic session. Antoch and colleaguesArticle evaluated the accuracy of these imaging modalities in a prospective study of patients with different histologically proven malignancies using histology and clinical-radiological follow-up as standards of reference. Overall TNM staging was correctly determined by PET/CT in 77% of patients and by whole-body MRI in 54% of patients. In an editorial, Blomqvist and TorkzadArticle discuss issues that are important to consider when assessing the use of whole-body imaging for tumor staging.


Uncontrolled observational studies have indicated that valve surgery is associated with improved outcomes in patients with complicated native valve infective endocarditis. Vikram and colleaguesArticle evaluated 6-month all-cause mortality in a cohort of patients with complicated, left-sided native valve endocarditis using multivariable modeling to adjust for prognostic imbalances at baseline and propensity analyses to control for confounding factors that affect treatment selection. Mortality at 6 months after baseline was significantly lower among patients who underwent valve surgery than among patients who received medical therapy alone in unadjusted analyses, in analyses that adjusted for baseline variables associated with mortality, and in a subset of patients matched by propensity to undergo valve surgery. In an editorial, DurackArticle suggests that surgery may offer the best opportunity to reduce the persistently high mortality rate in individuals with infective endocarditis.


The first cases in the global outbreak of severe acute respiratory syndrome (SARS) were reported in February 2003. From November 1, 2002 through August 7, 2003, a cumulative total of 8422 probable SARS cases and 916 SARS-related deaths were reported from 29 countries to the World Health Organization. Three articles in this issue of THE JOURNAL focus on this new infectious disease. Pang and colleaguesArticle describe and evaluate measures undertaken to control the largest local SARS outbreak, which occurred in Beijing, China, in March 2003. Loutfy and colleaguesArticle report the results of a preliminary study among patients with SARS comparing treatment with interferon alfacon-1 plus corticosteroids with corticosteroids alone. Gostin and colleaguesArticle discuss legal and ethical implications of public health strategies used by countries to control the SARS outbreak and recommendations for responding to future severe infectious disease threats. In an editorial, HughesArticle urges preparedness planning, heightened vigilance, timely reporting of disease, and interdisciplinary partnerships to contain the spread of newly recognized pathogens.


Mr G, a 50-year-old man who has hepatitis C and cirrhosis, failed to respond to antiviral therapy and is currently awaiting liver transplantation. Hanto discusses indications for liver transplantation, pretransplant evaluation, complications after liver transplantation, and posttransplant prognosis.


Researchers are seeking better methods and techniques for improving the survival of individuals who experience cardiac arrest.Article

Therapy with bacteriophage, bacteria-killing viruses, was largely abandoned with the development of antibiotics. But the emerging threat of antibiotic-resistant pathogens has sparked renewed interest in the approach.Article


For your patients: Information about severe acute respiratory syndrome (SARS).



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.